The Health Service Executive (HSE) has approved BIMZELEX (bimekizumab) in Ireland for adults living with moderate-to-severe ...

The HS market in the 7MM offers growth through innovative biologics and small molecules by 2034, driven by key pipeline agents like sonelokimab and povorcitnib. Opportunities include in-licensing, new ...

Obesity, diabetes, and other comorbidities increase GLP-1 agonist prescriptions in hidradenitis suppurativa. Learn more.

While glucocorticoids are generally effective as first-line treatment in IgG4-RS, this is not the case in primary Sjögren's syndrome, making it imperative that the 2 conditions, although similar, are ...